How Virus Existence Is Claimed Without Proof

No health institution anywhere in the world has been able to produce records showing that SARS-CoV-2, or any other claimed pathogenic virus, was ever physically separated from a diseased human being. What passes for virus discovery is a sequence of laboratory procedures that have never been properly controlled, genome assemblies done entirely in software, and definitions that have been quietly shifted over time to mean something weaker than what the words suggest.

• The word "isolation" in virology does not mean physical separation. It means growing material in a cell culture and observing that cells die
• Those same cells die from standard lab conditions alone, with no patient material added at all
• The SARS-CoV-2 reference genome is a software assembly, never confirmed to come from a real physical particle
• 209 health institutions across 35 countries could not produce purification records when formally asked
• PCR tests detect sequence matches. They were never clinically validated as diagnostic tools
• Animal experiments used as proof of viral disease lacked valid control groups and used unnatural exposure routes

What virus isolation actually requires

A virus, by virology's own definition, is a physical particle that enters a host cell, replicates inside it, and causes disease. Proving one exists means more than watching cells die in a dish or having software assemble sequences that resemble a database entry.

Physical isolation means separating the candidate particle from everything else in the sample, from the cells used in the culture, the culture medium, the antibiotics added to prevent contamination, and the natural cellular debris any biological mixture contains. Without that separation, there is no way to know which part of the mixture caused the observed effect, or whether the detected sequences belong to a particle rather than the cells themselves.

Virologists have consistently applied a weaker standard. Any procedure that produces observable effects and detectable sequences is called an isolation. The practical result is that every positive PCR result, every antibody test, and every vaccine formulation rests on a genomic template whose physical origin was never verified.

The cell culture problem

The standard method for claiming virus discovery involves adding patient material to a cell culture and observing whether the cells die or degenerate. This change is called a cytopathic effect, or CPE. CPEs are then taken as evidence that a virus was present in the patient material.

The critical flaw has been directly demonstrated. Researcher Dr Stefan Lanka subjected cell cultures to the same stressors used in standard virology protocols, repeated passaging and antibiotic exposure, without adding any patient material. CPEs appeared in every stressed condition. Cell death in a laboratory dish is produced by laboratory conditions, not necessarily by a virus. Until control experiments establish what happens in the absence of patient material, CPEs observed with patient material added cannot be attributed to any specific infectious agent.

This control experiment was not performed when John Enders and Thomas Peebles established the measles virus template in 1954. It has not been performed systematically since.

How the SARS-CoV-2 genome was constructed

The reference genome for SARS-CoV-2, deposited in GenBank as MN908947.1 on 5 January 2020, was assembled by Fan Wu et al. from the lung washings of a single patient with pneumonia. All RNA in the sample was randomly fragmented into pieces of around 150 nucleotides each, generating over 56 million fragments, which were then fed into assembly software. The software arranged overlapping fragments into longer sequences. The longest sequence, 30,474 nucleotides, was compared against existing database entries and found to match a bat coronavirus reference at 89.1% similarity. It was declared a new coronavirus genome.

That assembly was never confirmed to originate from inside a physical particle. The reference bat coronavirus it was compared against was itself assembled by the same process from bat intestinal tissue. When an independent team attempted to reproduce the Fan Wu assembly from the same raw data, they could not. The longest reproducible sequence was 672 nucleotides shorter and showed a 98.85% match to human ribosomal RNA, not a bat coronavirus. The PCR primers used in billions of COVID-19 tests worldwide were designed from this unverified assembly.

The PCR test cannot diagnose infection

PCR amplifies specific pre-selected sequences from a sample. If the target sequence is present, the reaction produces a detectable signal. This is analytical specificity, the ability to detect a chosen sequence. It is not diagnostic specificity, the ability to correctly identify people who are actually ill with a given disease. Professor Stephen Bustin, lead author of the internationally recognised MIQE Guidelines for PCR publication standards, said in a 2020 interview that calling a COVID-19 PCR result positive at 36 to 37 amplification cycles was "absolute nonsense." The clinical validation studies needed to establish whether a positive result corresponds to real disease were never done before the test was deployed globally.

The WHO adopted the Corman-Drosten PCR protocol, published in Eurosurveillance on 23 January 2020, before the paper had cleared peer review. A COVID-19 case was then defined as a person with laboratory confirmation of COVID-19 infection, regardless of clinical signs or symptoms. This treated a molecular amplification tool as a diagnostic gold standard without the validation that designation requires.

Freedom of information reveals the absence of evidence

Between 2020 and 2022, researcher Christine Massey coordinated formal information requests to 209 health and science institutions across more than 35 countries. Every institution either confirmed it held no records of SARS-CoV-2 being purified from a diseased human, or it redirected to cell culture experiments as evidence, which is a different procedure from physical purification. Institutions including the US Centers for Disease Control, the UK Health Security Agency, and New Zealand's Institute of Environmental Science and Research could not produce basic experimental records confirming their virus isolation papers had been conducted with appropriate controls.

The UKHSA, when asked to disclose the control methodology for a published viral culture paper, declined under a national security exemption, citing a WHO request not to release culture amplification details publicly. The CDC, when asked about the mock-infected controls in its own SARS-CoV-2 isolation publication, confirmed it held no records for those specific experimental details.

What this means for virology's broader claims

The methodological failures identified for SARS-CoV-2 are not specific to COVID-19. The same absence of physical isolation, the same uncontrolled cell culture experiments, and the same shifting of key definitions apply to every pathogen virology has named. The Tobacco Mosaic Virus discovery in 1903, the Rous sarcoma virus in 1911, and the measles virus template in 1954 each followed the same pattern: filtration experiments without controls, cell culture effects declared evidence of infection, and virus existence assumed rather than demonstrated. The viral hypothesis for Rous sarcoma was refuted in 1927 when the same cancer was reproduced using carcinogenic chemicals with no virus involved. That finding did not end the viral hypothesis. Rous received the Nobel Prize in Physiology or Medicine in 1966.

Virology's core claim, that specific submicroscopic particles cause specific infectious diseases, has been maintained for over a century without the physical isolation, characterisation, and controlled replication experiments the claim requires. The question is whether institutions and governments have been making significant decisions based on evidence that does not, under formal scrutiny, exist.

Where these ideas come from

The ideas in this section of the knowledge base come from the work of Dr Mark Bailey, specifically his essay A Farewell to Virology (Expert Edition), published through drsambailey.com on 15 September 2022. Dr Bailey is a medical doctor and researcher based in New Zealand who has published extensively on the methodological foundations of virology and the evidential basis for virus existence claims. His work examines primary scientific literature, Freedom of Information disclosures, and direct correspondence with virologists and health institutions to assess whether modern virology's claims hold up against the standards it nominally applies to itself. The original essay is available through drsambailey.com and is worth reading alongside the primary papers it examines.

The knowledge base itself is an independent work. Every concept has been studied, rewritten from scratch, and restructured for use in a multi-source advisory system. Nothing from the original has been reproduced. The knowledge has been transformed, not copied. The source is named clearly because the ideas deserve proper credit, and because the original work stands on its own merits.